GB0520800D0 - Viral treatment - Google Patents
Viral treatmentInfo
- Publication number
- GB0520800D0 GB0520800D0 GBGB0520800.4A GB0520800A GB0520800D0 GB 0520800 D0 GB0520800 D0 GB 0520800D0 GB 0520800 A GB0520800 A GB 0520800A GB 0520800 D0 GB0520800 D0 GB 0520800D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- viral treatment
- viral
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0520800A GB2431106A (en) | 2005-10-13 | 2005-10-13 | RNA inhibition of Venezuelan equine encephalitis virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0520800A GB2431106A (en) | 2005-10-13 | 2005-10-13 | RNA inhibition of Venezuelan equine encephalitis virus |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0520800D0 true GB0520800D0 (en) | 2005-11-23 |
GB2431106A GB2431106A (en) | 2007-04-18 |
Family
ID=35451654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0520800A Withdrawn GB2431106A (en) | 2005-10-13 | 2005-10-13 | RNA inhibition of Venezuelan equine encephalitis virus |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2431106A (en) |
-
2005
- 2005-10-13 GB GB0520800A patent/GB2431106A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2431106A (en) | 2007-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205935A1 (en) | Non-lithotripsic kidney-stone therapy | |
AP2907A (en) | Viral hepatitis treatment | |
SI1906772T1 (en) | Potato treatment | |
IL186408A0 (en) | Combination treatment methods | |
GB0504206D0 (en) | Combination therapy | |
GB0524103D0 (en) | Healing | |
GB0509052D0 (en) | Combination therapy | |
GB0516068D0 (en) | Well treatment | |
ZA200709627B (en) | Combination therapy | |
GB0416487D0 (en) | Modified virus | |
GB0511769D0 (en) | Treatment | |
GB0525540D0 (en) | New treatment | |
GB0507003D0 (en) | Therapeutic | |
GB0518720D0 (en) | Therapeutic combination | |
GB0502171D0 (en) | Well treatment | |
GB0606324D0 (en) | Condensate treatment | |
GB0426141D0 (en) | Treatment | |
GB0520800D0 (en) | Viral treatment | |
GB0518798D0 (en) | Viral inactivation | |
GB0500659D0 (en) | Combination therapy | |
GB0514347D0 (en) | Combination therapy | |
GB0513778D0 (en) | Combination therapy | |
GB0500658D0 (en) | Combination therapy | |
GB0526121D0 (en) | Combination therapy | |
GB0506726D0 (en) | Combination therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |